Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Chronic Graft Versus Host Disease
In brief
The primary objective of this study is to evaluate the effect of entospletinib (ENTO) on the best overall response rate in adults with chronic graft versus host disease (cGVHD) who are currently receiving systemic corticosteroids as part of first-line therapy for cGVHD.
Key facts
- Study ID
- NCT02701634
- Run by
- Gilead Sciences
- People needed
- 66
- Starts
- 2016-05-27
- Expected to finish
- 2018-03-06
- Last updated by the study team
- 2018-12-26
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Miami — Miami, Florida, United States
- Emory University — Atlanta, Georgia, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- University of Kansas Cancer Center — Westwood, Kansas, United States
- Weill Cornell Medical Center — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Taussig Cancer Institute — Cleveland, Ohio, United States
- Ohio State University, Wexner Medical Center — Columbus, Ohio, United States
- Vanderbilt University — Nashville, Tennessee, United States
- Princess Margaret — Toronto, Ontario, Canada
- Institut Paoli Calmettes — Marseille, France
- Hopital Saint Louis — Paris, France
- Institut Gustave Roussy — Villejuif, France
- Universitätsklinikum Carl Gustav Carus — Dresden, Germany
- Universitatsklinikum Frankfurt — Frankfurt am Main, Germany
- Universitatsklinikum Hamburg-Eppendorf — Hamburg, Germany
- Klinikum der Universitaet Regensburg — Regensburg, Germany
- Pusan National University Hospital — Busan, South Korea
- Samsung Medical Center — Seoul, South Korea
- Severance Hospital, Yonsei University Health System — Seoul, South Korea
- Hospital Universitario Vall d'Hebron — Barcelona, Spain
- Hospital General Universitario Gregorio Marañon — Madrid, Spain
- Hospital Universitario de Salamanca — Salamanca, Spain
- Hospital Universitario Marques de Valdecilla — Santander, Spain
- Hospital Universitario Virgen del Rocio — Seville, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.